Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 19 de 19
Filtrar
1.
J Card Surg ; 32(10): 604-612, 2017 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-28929526

RESUMEN

BACKGROUND: We analyzed our early and midterm results with aortic valve reimplantation surgery to determine the influence of Marfan syndrome and bicuspid valves on outcomes with this technique. METHODS: Between March 2004 and December 2015, 267 patients underwent aortic valve reimplantation operations. The mean diameter of the sinuses of Valsalva was 50 ± 3 mm and moderate/severe aortic regurgitation was present in 34.4% of these patients. A bicuspid aortic valve was present in 21% and 40% had Marfan syndrome. RESULTS: Overall 30-day mortality was 0.37% (1/267). Mean follow-up was 59.7 ± 38.7 months. Overall survival at 1, 3, and 5 years was 98 ± 8%, 98 ± 1%, and 94 ± 2%, respectively. Freedom from reoperation and aortic regurgitation >II was 99 ± 5%, 98 ± 8%, 96.7 ± 8%, and 99 ± 6%, 98 ± 1%, 98 ± 1%, respectively at 1, 3, and 5 years follow-up, with no differences between Marfan and bicuspid aortic valve groups. (p = 0.94 and p = 0.96, respectively). No endocarditis or thromboembolic complications were documented, and 93.6% of the patients did not receive any anticoagulation therapy. CONCLUSIONS: The reimplantation technique for aortic root aneurysms is associated with excellent clinical and functional outcomes at short and mid-term follow-up.


Asunto(s)
Aneurisma de la Aorta/etiología , Aneurisma de la Aorta/cirugía , Válvula Aórtica/anomalías , Válvula Aórtica/cirugía , Enfermedades de las Válvulas Cardíacas/complicaciones , Implantación de Prótesis de Válvulas Cardíacas/métodos , Síndrome de Marfan/complicaciones , Tratamientos Conservadores del Órgano/métodos , Adulto , Cuidados Posteriores , Anciano , Aneurisma de la Aorta/mortalidad , Insuficiencia de la Válvula Aórtica/etiología , Enfermedad de la Válvula Aórtica Bicúspide , Femenino , Implantación de Prótesis de Válvulas Cardíacas/mortalidad , Humanos , Masculino , Persona de Mediana Edad , Estudios Retrospectivos , Seno Aórtico/patología , Factores de Tiempo , Resultado del Tratamiento
2.
Rev. esp. cardiol. (Ed. impr.) ; 70(9): 727-735, sept. 2017. ilus, graf, tab
Artículo en Español | IBECS | ID: ibc-166500

RESUMEN

Introducción y objetivos: La mayoría de los dispositivos de asistencia ventricular (DAV) de larga duración utilizados actualmente son intracorpóreos y de flujo continuo. Sus principales inconvenientes son el coste elevado y la imposibilidad de ofrecer soporte biventricular. El objetivo de este estudio es describir los resultados de una estrategia de implante de un DAV paracorpóreo de flujo pulsátil como puente al trasplante (PAT) en pacientes adultos. Métodos: Análisis retrospectivo de las características, complicaciones y resultados de una serie unicéntrica de pacientes consecutivos tratados con el DAV EXCOR como PAT entre 2009 y 2015. Resultados: En este periodo se implantaron 25 DAV, 6 de ellos biventriculares. En 12 pacientes la indicación fue directamente PAT y en 13 puente a la decisión debido a la presencia de contraindicaciones potencialmente reversibles o posibilidad de recuperación. Veinte pacientes (80%) alcanzaron el objetivo del trasplante cardiaco tras una mediana de soporte de 112 días (rango 8-239). Las principales complicaciones fueron: infecciosas (52% de los pacientes), neurológicas (32%, la mitad de ellas mortales), hemorrágicas (28%) y fallo del DAV que obligó a cambiar algún componente de este (28%). Conclusiones: El 80% de los pacientes tratados con el DAV EXCOR como PAT alcanzaron el objetivo tras una mediana de soporte de casi 4 meses. Las complicaciones más frecuentes fueron las infecciosas y las más graves las neurológicas. El empleo de estos DAV de flujo pulsátil como PAT, en nuestro medio, es una estrategia factible que consigue resultados similares a los DAV de flujo continuo (AU)


Introduction and objectives: Most long-term ventricular assist devices (VADs) that are currently implanted are intracorporeal continuous-flow devices. Their main limitations include their high cost and inability to provide biventricular support. The aim of this study was to describe the results of using paracorporeal pulsatile-flow VADs as a bridge to transplant (BTT) in adult patients. Methods: Retrospective analysis of the characteristics, complications, and outcomes of a single-center case series of consecutive patients treated with the EXCOR VAD as BTT between 2009 and 2015. Results: During the study period, 25 VADs were implanted, 6 of them biventricular. Ventricular assist devices were indicated directly as a BTT in 12 patients and as a bridge to decision in 13 due to the presence of potentially reversible contraindications or chance of heart function recovery. Twenty patients (80%) were successfully bridged to heart transplant after a median of 112 days (range, 8-239). The main complications included infectious (52% of patients), neurological events (32%, half of them fatal), bleeding (28%), and VAD malfunction requiring component replacement (28%). Conclusions: Eighty percent of patients with the EXCOR VAD as BTT achieved the goal after an average of almost 4 months of support. The most frequent complications were infectious, and the most severe were neurological. In our enivonment, the use of these pulsatile-flow VAD as BTT is a feasible strategy that obtains similar outcomes to those of intracorporeal continuous-flow devices (AU)


Asunto(s)
Humanos , Adulto , Corazón Auxiliar , Disfunción Ventricular/cirugía , Trasplante de Corazón/métodos , Acondicionamiento Pretrasplante/métodos , Flujo Pulsátil/fisiología , Estudios Retrospectivos , Anticoagulantes/administración & dosificación
3.
Rev Esp Cardiol (Engl Ed) ; 70(9): 727-735, 2017 Sep.
Artículo en Inglés, Español | MEDLINE | ID: mdl-28366497

RESUMEN

INTRODUCTION AND OBJECTIVES: Most long-term ventricular assist devices (VADs) that are currently implanted are intracorporeal continuous-flow devices. Their main limitations include their high cost and inability to provide biventricular support. The aim of this study was to describe the results of using paracorporeal pulsatile-flow VADs as a bridge to transplant (BTT) in adult patients. METHODS: Retrospective analysis of the characteristics, complications, and outcomes of a single-center case series of consecutive patients treated with the EXCOR VAD as BTT between 2009 and 2015. RESULTS: During the study period, 25 VADs were implanted, 6 of them biventricular. Ventricular assist devices were indicated directly as a BTT in 12 patients and as a bridge to decision in 13 due to the presence of potentially reversible contraindications or chance of heart function recovery. Twenty patients (80%) were successfully bridged to heart transplant after a median of 112 days (range, 8-239). The main complications included infectious (52% of patients), neurological events (32%, half of them fatal), bleeding (28%), and VAD malfunction requiring component replacement (28%). CONCLUSIONS: Eighty percent of patients with the EXCOR VAD as BTT achieved the goal after an average of almost 4 months of support. The most frequent complications were infectious, and the most severe were neurological. In our enivonment, the use of these pulsatile-flow VAD as BTT is a feasible strategy that obtains similar outcomes to those of intracorporeal continuous-flow devices.


Asunto(s)
Insuficiencia Cardíaca/terapia , Trasplante de Corazón , Corazón Auxiliar , Adulto , Femenino , Hemorragia/epidemiología , Humanos , Infecciones/epidemiología , Masculino , Persona de Mediana Edad , Estudios Retrospectivos , Accidente Cerebrovascular/epidemiología , Trombosis/epidemiología , Factores de Tiempo , Resultado del Tratamiento
4.
Eur J Cardiothorac Surg ; 50(6): 1149-1157, 2016 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-27283156

RESUMEN

OBJECTIVES: Endocarditis in patients with ascending aortic prosthetic graft (AAPG) is a life-threatening complication. The purpose of this study was to examine the clinical presentation and prognosis of patients with AAPG endocarditis included in a large prospective infectious endocarditis multicentre study. METHODS: From January 2008 to April 2015, 3200 consecutive patients with infectious endocarditis according to the modified Duke criteria, were prospectively included in the 'Spanish Collaboration on Endocarditis Registry (GAMES)' registry. Twenty-seven definite episodes of endocarditis (0.8%) occurred in patients with AAPG. RESULTS: During the study period, 27 cases of endocarditis were detected in patients with AAPG. The median age of patients was 61 years [interquartile range (IQR) 51-68 years] and 23 (85.2%) patients were male. The median time from AAPG surgery to the episode of AAPG infection was 24 months (IQR 6-108 months). The most frequently isolated micro-organisms were coagulase-negative staphylococci and S. aureus (11 patients, 40.7%). Four patients (14.8%) underwent medical treatment, whereas surgery was performed in 21 (77.7%). Two patients (7.4%) died before surgery could be performed. The median hospital stay prior to surgery was 7 days (IQR 4-21 days). Surgery consisted of replacing previous grafts with a composite aortic graft (10 cases) or aortic homograft (2 patients), and removal of a large vegetation attached to the valve of a composite tube (1 case). Nine patients had an infected aortic valve prosthesis without evidence of involvement of the AAPG. Isolated redo-aortic valve replacement was performed in 8 (88.9%) of these patients. Reinfection occurring during 1 year of follow-up was not detected in any patient. Two patients (7.4%) died while awaiting surgery and 6 did so after surgery (22.2%). A New York Heart Association (NYHA) Class IV was associated with mortality in patients undergoing surgery (P < 0.019). CONCLUSIONS: Most cases of endocarditis in patients with AAPG occur late after initial surgery. Mortality rate of patients with AAPG endocarditis who undergo surgery is acceptable. NYHA Class IV before surgery is associated with an increased postoperative mortality.


Asunto(s)
Aorta/cirugía , Implantación de Prótesis Vascular/efectos adversos , Endocarditis Bacteriana/etiología , Injerto Vascular/efectos adversos , Anciano , Prótesis Vascular , Implantación de Prótesis Vascular/métodos , Endocarditis Bacteriana/epidemiología , Endocarditis Bacteriana/microbiología , Femenino , Humanos , Masculino , Persona de Mediana Edad , Sistema de Registros , Infecciones Estafilocócicas/epidemiología , Infecciones Estafilocócicas/etiología , Injerto Vascular/métodos
7.
Infection ; 42(2): 425-8, 2014 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-24163221

RESUMEN

A 59-year-old Caucasian male presented with progressive dyspnea, arthralgias and fever for three days. A diastolic regurgitation murmur was detected in the aortic area. A transesophageal echocardiograph showed several vegetations and severe aortic regurgitation. Blood cultures yielded Neisseria gonorrhoeae beta-lactamase negative. The patient had not noticed any urogenital discomfort or urethral discharge. The patient successfully underwent surgery for septal abscess debridement. The patient received ceftriaxone 2 g bid for eight weeks and the clinical follow-up was uneventful. The review of the literature revealed a total of the 38 additional cases reported between 1980 and the present. The majority of the patients were young, male and with native valve involvement. There has been a clear tendency for left-sided valve involvement (especially in the aortic valve). All valve cultures were reported negative despite, in most cases, the marked tissue destruction. Polymerase chain reaction was performed in two patients and positive results were shown in both. Cultures of exudates from other locations were negative in most cases. One striking fact is the high proportion of patients who underwent surgery (72 %). Information regarding antibiotic sensitivity was available in 28 cases, with penicillin resistance reported in six patients (21 %) and intermediate sensitivity in four patients (14 %). Resistance to ciprofloxacin was reported in two cases (7 %). A rapid increase and distribution of isolates resistant to third generation cephalosporins have been recently detected. The mortality is high, particularly taking into account that most were young patients who had not presented previous heart disease.


Asunto(s)
Antibacterianos/uso terapéutico , Endocarditis Bacteriana/tratamiento farmacológico , Endocarditis Bacteriana/cirugía , Gonorrea/complicaciones , Neisseria gonorrhoeae/aislamiento & purificación , Recuento de Colonia Microbiana , Farmacorresistencia Bacteriana , Endocarditis Bacteriana/microbiología , Endocarditis Bacteriana/mortalidad , Gonorrea/tratamiento farmacológico , Gonorrea/mortalidad , Gonorrea/cirugía , Humanos , Masculino , Persona de Mediana Edad , Neisseria gonorrhoeae/efectos de los fármacos , Neisseria gonorrhoeae/fisiología , Reacción en Cadena de la Polimerasa , Resultado del Tratamiento
8.
Rev. esp. cardiol. (Ed. impr.) ; 66(10): 797-802, oct. 2013.
Artículo en Español | IBECS | ID: ibc-115595

RESUMEN

Introducción y objetivos. Los receptores de trasplante cardiaco que sobreviven más de 20 años están aumentando. Poco se conoce de su seguimiento, sus comorbilidades y su mortalidad. Identificar predictores de larga supervivencia puede guiar la selección de candidatos para los donantes disponibles. Métodos. Se revisó la información sobre la clase funcional, las comorbilidades y la mortalidad de pacientes trasplantados antes de 1992. Para identificar los predictores de supervivencia > 20 años, se construyó un modelo de regresión logística utilizando las variables asociadas a supervivencia en el análisis univariable. Resultados. Se comparó a 39 supervivientes con seguimiento > 20 años (el 26% del total) con 90 pacientes que sobrevivieron entre 1 y 20 años. Las principales complicaciones fueron hipertensión, disfunción renal, infecciones y neoplasias. Tras 30 meses de seguimiento, 6 murieron, lo que implica una mortalidad del 6%/año (frente a un 2,5-3% en los años 1 a 19). Las principales causas de muerte fueron infección (50%), cáncer (33%) y vasculopatía del injerto (17%). Los supervivientes eran más jóvenes y delgados, y tenían cardiopatía no isquémica y menos isquemia en cirugía. La regresión logística identificó la edad del receptor < 45 años (odds ratio = 3,9; intervalo de confianza del 95%, 1,6-9,7; p = 0,002) y la miocardiopatía idiopática (odds ratio = 3; intervalo de confianza del 95%, 1,4-7,8; p = 0,012) como predictores independientes de supervivencia > 20 años. Conclusiones. En nuestra serie, más del 25% sobrevive más de 20 años con el mismo injerto y lleva vida independiente a pesar de las comorbilidades. La edad del receptor < 45 años y la miocardiopatía idiopática se asociaron a larga supervivencia. Estos datos pueden ayudar a la asignación de donantes (AU)


Introduction and objectives. The number of heart-transplant recipients exceeding 20 years of follow-up is steadily increasing. However, little is known about their functional status, comorbidities, and mortality. Identifying the predictors of prolonged survival could guide the selection of candidates for the low number of available donors. Methods. Functional status, morbidities, and mortality of heart-transplant patients between 1984 and 1992 were analyzed. To identify predictors of 20-year survival, a logistic regression model was constructed using the covariates associated with survival in the univariate analysis. Results. A total of 39 patients who survived 20 years (26% of patients transplanted before 1992) were compared to 90 recipients from the same period who died between 1 and 20 years post-transplantation. Major complications were hypertension, renal dysfunction, infections, and cancer. After a mean follow-up of 30 months, 6 survivors had died, yielding a mortality rate of 6% per year (vs 2.5%-3% in years 1-19). Causes of mortality were infection (50%), malignancy (33%), and allograft vasculopathy (17%). Long-term survivors were younger and leaner, and had nonischemic cardiomyopathy and lower ischemic time. Logistic regression identified recipient age <45 years (odds ratio=3.9; 95% confidence interval, 1.6-9.7; P=.002) and idiopathic cardiomyopathy (odds ratio=3; 95% confidence interval, 1.4-7.8; P=.012) as independent predictors for 20-year survival. Conclusions. One fourth of all heart-transplant patients in our series survived >20 years with the same graft, and most enjoy independent lives despite significant comorbidities. Recipient age <45 years and idiopathic cardiomyopathy were associated with survival beyond 2 decades. These data may help decide donor allocation (AU)


Asunto(s)
Adulto , Persona de Mediana Edad , Humanos , Trasplante de Corazón/métodos , Trasplante de Corazón , Calidad de Vida , Supervivencia de Injerto/fisiología , Cardiomiopatía Hipertrófica/complicaciones , Terapia de Inmunosupresión/instrumentación , Terapia de Inmunosupresión/métodos , Factores de Riesgo , Trasplante de Corazón/rehabilitación , Trasplante de Corazón/tendencias , Comorbilidad , Oportunidad Relativa , Tasa de Supervivencia , Intervalos de Confianza , Índice de Masa Corporal , Análisis Multivariante
10.
Rev Esp Cardiol (Engl Ed) ; 66(10): 797-802, 2013 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-24773860

RESUMEN

INTRODUCTION AND OBJECTIVES: The number of heart-transplant recipients exceeding 20 years of follow-up is steadily increasing. However, little is known about their functional status, comorbidities, and mortality. Identifying the predictors of prolonged survival could guide the selection of candidates for the low number of available donors. METHODS: Functional status, morbidities, and mortality of heart-transplant patients between 1984 and 1992 were analyzed. To identify predictors of 20-year survival, a logistic regression model was constructed using the covariates associated with survival in the univariate analysis. RESULTS: A total of 39 patients who survived 20 years (26% of patients transplanted before 1992) were compared to 90 recipients from the same period who died between 1 and 20 years post-transplantation. Major complications were hypertension, renal dysfunction, infections, and cancer. After a mean follow-up of 30 months, 6 survivors had died, yielding a mortality rate of 6% per year (vs 2.5%-3% in years 1-19). Causes of mortality were infection (50%), malignancy (33%), and allograft vasculopathy (17%). Long-term survivors were younger and leaner, and had nonischemic cardiomyopathy and lower ischemic time. Logistic regression identified recipient age <45 years (odds ratio=3.9; 95% confidence interval, 1.6-9.7; P=.002) and idiopathic cardiomyopathy (odds ratio=3; 95% confidence interval, 1.4-7.8; P=.012) as independent predictors for 20-year survival. CONCLUSIONS: One fourth of all heart-transplant patients in our series survived >20 years with the same graft, and most enjoy independent lives despite significant comorbidities. Recipient age <45 years and idiopathic cardiomyopathy were associated with survival beyond 2 decades. These data may help decide donor allocation.


Asunto(s)
Causas de Muerte , Trasplante de Corazón/mortalidad , Trasplante de Corazón/métodos , Calidad de Vida , Adulto , Factores de Edad , Análisis de Varianza , Bases de Datos Factuales , Femenino , Estudios de Seguimiento , Rechazo de Injerto , Supervivencia de Injerto , Trasplante de Corazón/psicología , Humanos , Estimación de Kaplan-Meier , Masculino , Persona de Mediana Edad , Complicaciones Posoperatorias/mortalidad , Complicaciones Posoperatorias/fisiopatología , Estudios Retrospectivos , Factores Sexuales , España , Análisis de Supervivencia , Sobrevivientes/estadística & datos numéricos , Factores de Tiempo , Donantes de Tejidos , Adulto Joven
13.
J Heart Lung Transplant ; 30(6): 644-51, 2011 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-21470878

RESUMEN

BACKGROUND: Primary graft failure (PGF) is the leading cause of early mortality after heart transplantation (HT). Our aim is to propose a working definition of PGF and to develop a predictive risk score. METHODS: PGF was defined by four criteria reflecting significant myocardial dysfunction, severe hemodynamic impairment, early onset after HT, and absence of secondary causes of graft dysfunction. We identified independent risk factors for PGF in a derivation series of 621 HTs and constructed a predictive model. After proving its internal consistency we tested the model in a prospective validation series. RESULTS: The incidence and lethality of PGF in our series were 9% and 80%, respectively. We identified 6 multivariate risk factors for PGF (Right atrial pressure ≥ 10 mm Hg, recipient Age ≥ 60 years, Diabetes mellitus, Inotrope dependence, donor Age ≥ 30 years, Length of ischemic time ≥ 240 minutes--i.e., RADIAL). Analysis of isolated right ventricular failure showed similar predictors. The RADIAL score was obtained by adding 1 point for each of these factors present in a given HT. PGF incidence increased significantly as the RADIAL score increased (p < 0.001 for trend). Rates of actual and predicted PGF incidence for RADIAL subgroups showed a good correlation (C-statistic = 0.74). In a prospective validation cohort, RADIAL score kept its predictive ability. CONCLUSIONS: PGF as defined by these criteria showed a high impact on early post-HT mortality in our series. The RADIAL score showed good ability to predict the development of PGF, and could be useful in the prevention and early treatment of this complication.


Asunto(s)
Rechazo de Injerto/etiología , Trasplante de Corazón/efectos adversos , Adolescente , Adulto , Anciano , Niño , Femenino , Rechazo de Injerto/epidemiología , Rechazo de Injerto/mortalidad , Humanos , Incidencia , Masculino , Persona de Mediana Edad , Estudios Prospectivos , Estudios Retrospectivos , Medición de Riesgo/métodos , Factores de Riesgo , Terminología como Asunto , Adulto Joven
14.
Physiol Meas ; 31(12): 1553-65, 2010 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-20980717

RESUMEN

In recent times, significant effort has been made to understand the mechanical behaviour of the arterial wall and how it is affected by the different vascular pathologies. However, to be able to interpret the results correctly, it is essential that the influence of other factors, such as aging or anisotropy, be understood. Knowledge of mechanical behaviour of the aorta has been customarily constrained by lack of data on fresh aortic tissue, especially from healthy young individuals. In addition, information regarding the point of rupture is also very limited. In this study, the mechanical behaviour of the descending thoracic aorta of 28 organ donors with no apparent disease, whose ages vary from 17 to 60 years, is evaluated. Tensile tests up to rupture are carried out to evaluate the influence of age and wall anisotropy. Results reveal that the tensile strength and stretch at failure of healthy descending aortas show a significant reduction with age, falling abruptly beyond the age of 30. This fact places age as a key factor when mechanical properties of descending aorta are considered.


Asunto(s)
Aorta Torácica/fisiología , Salud , Adolescente , Adulto , Fenómenos Biomecánicos/fisiología , Codo/fisiología , Femenino , Humanos , Masculino , Persona de Mediana Edad , Factores de Riesgo , Resistencia a la Tracción/fisiología , Adulto Joven
15.
Rev Esp Cardiol ; 63(5): 598-601, 2010 May.
Artículo en Inglés | MEDLINE | ID: mdl-20450854

RESUMEN

Intravascular ultrasound (IVUS) has been successfully used to guide the implantation of stents in the thoracic aorta. However, its accuracy in measuring the diameter of the aortic lumen has not been clearly established. Thirteen patients with thoracic aortic disease underwent IVUS, and lumen diameter measurements were compared with those obtained by CT or magnetic resonance imaging. A total of 31 comparable measurements were obtained. The correlation was good (r=0.98; P< .001), with IVUS tending to give a larger minimum diameter than CT (systematic error, 0.59+/-1.8 mm; P=.077). Given that the aorta is often not circular, the diameter obtained by IVUS was also compared to the mean diameter obtained by CT, and it was found that these two measurements were more closely related (P=.425), except in aortic segments with significant eccentricity (i.e., >10%). In conclusion, IVUS was a reliable tool for measuring the diameter of the aorta, particularly in concentric segments where stents are normally placed. Consequently, IVUS could supplement conventional imaging techniques.


Asunto(s)
Aorta Torácica/diagnóstico por imagen , Ultrasonografía Intervencional/métodos , Adulto , Anciano , Aorta Torácica/cirugía , Aneurisma de la Aorta Torácica/diagnóstico por imagen , Aneurisma de la Aorta Torácica/cirugía , Procedimientos Quirúrgicos Cardíacos , Femenino , Humanos , Imagen por Resonancia Magnética , Masculino , Persona de Mediana Edad , Tomografía Computarizada por Rayos X , Adulto Joven
16.
Rev. esp. cardiol. (Ed. impr.) ; 63(5): 598-601, mayo 2010. ilus
Artículo en Español | IBECS | ID: ibc-79361

RESUMEN

El ultrasonido intravascular (IVUS) se ha utilizado con éxito para guiar la implantación de endoprótesis en aorta torácica. Sin embargo, su precisión para medir la luz aórtica no está definitivamente establecida. Evaluamos con IVUS a 13 pacientes con enfermedad de la aorta torácica, comparando el diámetro luminal con las medidas de tomografía computarizada (TC) o resonancia magnética. Se obtuvieron 31 mediciones comparables. La correlación fue buena (r = 0,98; p < 0,001), con un ligero sesgo positivo del IVUS respecto al diámetro mínimo por TC (error sistemático, 0,59 ± 1,8 mm; p = 0,077). Dado que la aorta con frecuencia no es circular, se comparó también con el diámetro medio de la TC, obteniéndose mayor aproximación a las medidas de IVUS (p = 0,425), excepto en segmentos con excentricidad significativa (> 10%). En conclusión, el IVUS resulta fiable para la medición de diámetros aórticos, especialmente en segmentos concéntricos donde se fijan las endoprótesis, y puede complementar las técnicas de imagen convencionales (AU)


Intravascular ultrasound (IVUS) has been successfully used to guide the implantation of stents in the thoracic aorta. However, its accuracy in measuring the diameter of the aortic lumen has not been clearly established. Thirteen patients with thoracic aortic disease underwent IVUS, and lumen diameter measurements were compared with those obtained by CT or magnetic resonance imaging. A total of 31 comparable measurements were obtained. The correlation was good (r=0.98; P < .001), with IVUS tending to give a larger minimum diameter than CT (systematic error, 0.59±1.8 mm; P=.077). Given that the aorta is often not circular, the diameter obtained by IVUS was also compared to the mean diameter obtained by CT, and it was found that these two measurements were more closely related (P=.425), except in aortic segments with significant eccentricity (i.e., >10%). In conclusion, IVUS was a reliable tool for measuring the diameter of the aorta, particularly in concentric segments where stents are normally placed. Consequently, IVUS could supplement conventional imaging techniques (AU)


Asunto(s)
Humanos , Ultrasonografía Intervencional/métodos , Aneurisma de la Aorta Torácica/cirugía , Angioplastia de Balón/métodos , Coartación Aórtica/cirugía , Rotura de la Aorta/cirugía
17.
Rev Esp Cardiol ; 60(3): 259-67, 2007 Mar.
Artículo en Español | MEDLINE | ID: mdl-17394871

RESUMEN

INTRODUCTION AND OBJECTIVES: The thermomechanical behavior of human arteries is still not well characterized despite its importance for understanding arterial physiology, and for evaluating and improving surgical procedures. The aim of this study was to provide, for the first time, experimental data illustrating how the mechanical responses of two types of human artery -the carotid artery and the aorta- are affected by changes in temperature. METHODS: The mechanical properties of the arteries were derived in vitro from internal pressure-external diameter curves measured at four different temperatures (i.e., 17, 27, 37 and 42 degree C). Coefficients of expansion and stiffness were obtained by thermomechanical analysis. The condition of the arterial wall was determined histologically. RESULTS: The aorta and the carotid artery became slightly more compliant as the temperature increased. In both vessels, the coefficient of expansion depended critically on internal pressure. At low pressures, the coefficient of expansion was negative (i.e., the vessel contracted when heated), whereas close to a specific threshold pressure, which is different for each type of artery, the coefficient became positive. CONCLUSIONS: The mechanical behavior of arteries is affected by the combination of internal pressure and temperature. Consequently, the effect of this combination should be taken into account in clinical situations involving a change in temperature. Moreover, the strength of the effect depends on the type of artery under study. As a result, more detailed experimental data focusing on vessels of clinical interest are required.


Asunto(s)
Aorta/fisiología , Arterias Carótidas/fisiología , Humanos , Técnicas In Vitro , Presión , Estrés Mecánico , Temperatura
18.
Rev. esp. cardiol. (Ed. impr.) ; 60(3): 259-267, mar. 2007. ilus, graf
Artículo en Es | IBECS | ID: ibc-053675

RESUMEN

Introducción y objetivos. La respuesta termomecánica de las arterias humanas es poco conocida a pesar de su importancia para la comprensión de la fisiología arterial, y para la evaluación y mejora de los procedimientos quirúrgicos. El objetivo de este trabajo es aportar por vez primera datos experimentales que muestren cómo se ve afectada la respuesta mecánica de dos tipos de arterias humanas ­aorta y carótida­ por los cambios de temperatura. Métodos. La respuesta mecánica de las arterias se ha obtenido in vitro a través de la medición de las curvas presión interior-diámetro exterior para 4 temperaturas (17, 27, 37 y 42 oC). Se ha realizado un análisis termomecánico para obtener los coeficientes de dilatación y la rigidez del material. El estado de la pared arterial se ha evaluado mediante análisis histológico. Resultados. Las arterias aorta y carótida aumentan ligeramente su flexibilidad con la temperatura. El coeficiente de dilatación de ambos vasos depende críticamente de la presión interior aplicada. A bajas presiones, el coeficiente de dilatación es negativo (el vaso se contrae cuando se calienta), mientras que por encima de cierta presión umbral ­distinta para cada tipo de arteria­ el coeficiente de dilatación se hace positivo. Conclusiones. El efecto combinado de la presión interior y la temperatura afecta al comportamiento de las arterias y, por ello, debe ser tenido en cuenta al abordar situaciones clínicas que impliquen cambios de temperatura. La intensidad de este efecto depende del tipo de arteria estudiada, lo que requiere la obtención de datos más detallados, centrados en los vasos de interés clínico


Introduction and objectives. The thermomechanical behavior of human arteries is still not well characterized despite its importance for understanding arterial physiology, and for evaluating and improving surgical procedures. The aim of this study was to provide, for the first time, experimental data illustrating how the mechanical responses of two types of human artery ­the carotid artery and the aorta­ are affected by changes in temperature. Methods. The mechanical properties of the arteries were derived in vitro from internal pressure­external diameter curves measured at four different temperatures (i.e., 17, 27, 37 and 42 oC). Coefficients of expansion and stiffness were obtained by thermomechanical analysis. The condition of the arterial wall was determined histologically. Results. The aorta and the carotid artery became slightly more compliant as the temperature increased. In both vessels, the coefficient of expansion depended critically on internal pressure. At low pressures, the coefficient of expansion was negative (i.e., the vessel contracted when heated), whereas close to a specific threshold pressure, which is different for each type of artery, the coefficient became positive. Conclusions. The mechanical behavior of arteries is affected by the combination of internal pressure and temperature. Consequently, the effect of this combination should be taken into account in clinical situations involving a change in temperature. Moreover, the strength of the effect depends on the type of artery under study. As a result, more detailed experimental data focusing on vessels of clinical interest are required


Asunto(s)
Masculino , Femenino , Adulto , Humanos , Aorta/fisiología , Arterias Carótidas/fisiología , Presión Sanguínea/fisiología , Sistemas Presurizados , Cadáver , Temperatura Corporal/fisiología
19.
An. cir. card. cir. vasc ; 11(2): 111-114, mar.-abr. 2005. ilus
Artículo en Es | IBECS | ID: ibc-037538

RESUMEN

Los aneurismas coronarios de gran tamaño, no ateroscleróticos y localizados en el tronco común de la arteria coronaria izquierda son excepcionales. Presentamos el caso de un paciente de 25 años, que a raíz de un evento coronario agudo fue diagnosticado de un aneurisma gigante en el tronco común izquierdo y enfermedad de 2 vasos. Discutimos el diagnóstico diferencial y postulamos como etiología más probable las secuelas de una enfermedad de Kawasaki atípica. El paciente fue sometido con éxito a una revascularización arterial completa del ventrículo izquierdo asociada a ligadura de la circunfleja proximal


Giant, non atherosclerotic aneurysms of the left main coronary artery are exceptional. We report the case of a 25-year-old patient who was diagnosed of a giant aneurysm of the left main coronary artery associated with two-vessel disease after the onset of an acute coronary event. Differential diagnosis is discussed and delayed sequelae of an atypical Kawasaki disease is presented as the most likely etiology. The patient underwent successful complete arterial revascularization of the left ventricle, associated with proximal circumflex coronary artery occlusion


Asunto(s)
Masculino , Adulto , Humanos , Aneurisma Coronario/diagnóstico , Aneurisma Coronario/cirugía , Aneurisma Coronario/etiología , Enfermedad Coronaria/diagnóstico , Enfermedad Coronaria/cirugía , Síndrome Mucocutáneo Linfonodular/diagnóstico , Síndrome Mucocutáneo Linfonodular/cirugía , Revascularización Miocárdica/métodos , Cirugía Torácica/métodos , Diagnóstico Diferencial , Revascularización Miocárdica/tendencias , Revascularización Miocárdica , Vena Safena/lesiones , Vena Safena/patología , Cirugía Torácica/tendencias
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA